The number of heart attack patients seeking urgent hospital care has dropped Read more. We hope this finds you, your family, your staff, patients and organization Read more. Affidea partners with ScreenPoint Medical to increase diagnostic accuracy of screening mammography.

Author:Zulkijas Talkis
Language:English (Spanish)
Genre:Health and Food
Published (Last):4 April 2007
PDF File Size:12.28 Mb
ePub File Size:11.54 Mb
Price:Free* [*Free Regsitration Required]

Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies. Got It. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media. Login Join. Subscribe Free Magazine eNewsletter. Kuros Biosciences Ltd. As a result of the acquisition, Kuros accelerates its transition to commercial stage with two products expected to be ready for commercialization in the EU in , one of which may also obtain U.

The acquisition further provides Kuros with an EU operation in the Netherlands with certified and GMP-controlled manufacturing capabilities. After the acquisition, Kuros has attractive prospects based on a pipeline of products that target several key market opportunities, with a focus on orthobiologics, as well as an EU hub for its clinical and distribution operations. The company is positioned as a technology leader in both synthetic and biologic bone graft substitutes.

Its promising product candidates include: MagnetOs, an orthobiologic. A putty formulation of the product is currently in development. Neuroseal KUR , a biomaterial designed for dural sealing is being submitted for CE mark with market launch planned for KUR and KUR, two orthobiologic products, have been successfully tested in large, controlled Phase 2b clinical trials.

Further development continues as planned. In addition, van der Velden and Prof. Under the terms of the proposed combination, Kuros will issue a total of up to 2. About 1. A further 0. Provided all milestones are achieved, current Kuros shareholders will own about 71 percent of the combined firm. The companies have undertaken reciprocal due diligence.

The Board of Directors and shareholders of Xpand have approved the transaction. Closing of the transaction is expected within the next few weeks and is contingent upon certain conditions, amongst others the issuance of a listing prospectus and the listing of the new Kuros shares on the SIX Swiss Exchange.

Xpand Biotechnology BV develops products for bone repair and regeneration that are based on its proprietary surface science technology. Related Searches. Suggested For You. Master Bond Inc. LaVezzi Precision, Inc.

Surgical Sophistication. Sites that contribute the data will be able to monitor COVID's on patients undergoing future joint replacement procedures. Espire Elbow prosthetic arm reflects the anatomical shape and function of the elbow.

Orthopedic Procedures This Year. More than eight in 10 musculoskeletal procedures are being delayed, postponed or cancelled, estimates GlobalData.

Designed for fast, easy application to aid advanced range of motion control and protection. Additional FDA clearances roll in for growing spinal manufacturer to be available in the third quarter.

The patents in question were related to instruments used with off-the-shelf knee, hip, and shoulder implants. Conventus Orthopaedics Acquires Flower Orthopedics. Flower's Ready-for-Surgery platform reduces exposure to bioburden while enhancing OR efficiencies. Each implant expands to 4.

HA coating enhances amount of fixation possible between pedicle screw and surrounding bone in osteoporotic patients. The clearance marks the continued expansion of the company's portfolio to address additional complications in the foot. Brian J. Breaking News.

Miltec UV, Robert H. Fragrance Foundation Announces Finalists. Velox Launches New Website. Puig Acquires Charlotte Tilbury Beauty. Latest Breaking News From Happi. Arbonne Recalls Body Wash.

Coty Can't Keep Away from Kardashians. Positive ID Labels adds Xeikon Acucote expands digital portfolio. Esko, AVT announce business integration. Autoneum Restarts Production of Automotive Components. Emuge Celebrates th Anniversary.


Kuros is Acquiring Xpand to Create Orthobiologics Firm

Globus Medical Inc. Vertebral body replacement devices, namely, implants comprised of artificial materials for use in spinal surgical procedures. Or, contact the owner Globus Medical Inc. On Thursday, April 21, , a U. The USPTO makes this data available for search by the public so that individuals can locate ownership information for intellectual property, much the same way a county might make real estate property ownership information available.


XPAND Trademark Information

Skip to main content. Published: Mar 18, The new system significantly reduces the time required for surgeons to perform multilevel corpectomies by offering an unprecedented array of interoperative options. It also extends Globus Medical's portfolio for trauma, tumor, and advanced degenerative disease solutions. The resulting lordosis is contained in the endplate angles and within the shape of the implant itself, enabling surgeons to match the natural anatomy of the body.

Related Articles